Search clinical trials for: Variant of Defocus Incorporated Spectacle lens (DG2)

Total 66 results

The Hong Kong Polytechnic University
HOYA Lens Thailand LTD.

Recruiting

Effectiveness of the Defocus Incorporated Spectacle Lenses on Fast Progressing Myope

Myopia

Hong Kong
Czech Technical University in Prague

Active, not recruiting

Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults

Myopia

Czechia
Shanghai Eye Disease Prevention and Treatment Center

Recruiting

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

Myopia, Progressive

China
Vejle Hospital

Active, not recruiting

The Immediate Effect of Defocus Spectacles On the Choroid Thickness Using Optical Coherence Tomography on Children (TIDOCT)

Myopia

Denmark
Vejle Hospital

Recruiting

Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Danish Children Aged 6-12 Years. (NISDO)

Myopia

Denmark
Zhongshan Ophthalmic Center, Sun Yat-sen University

Active, not recruiting

Effectiveness and Safety of Partition Multi-point Defocused Myopia Management Spectacle Lens in Myopia Control

Myopia

China
The Hong Kong Polytechnic University

Completed

Myopia Control With Simultaneous Vision Approach

Myopia

China
Alanna Nattis, DO

Active, not recruiting

Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement

Cataract | Presbyopia | Cataract Senile

United States
Newsom Eye & Laser Center

Completed

Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye

Cataract

United States
The Hong Kong Polytechnic University
The University of Hong Kong

Active, not recruiting

Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine

Myopia

Hong Kong
Thomas Nagy
Sengi

Terminated

Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material

Cataract

Canada
The Hong Kong Polytechnic University
The University of Hong Kong

Not yet recruiting

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control

Myopia

Hong Kong
Berkeley Eye Center

Recruiting

Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients

Pseudophakia

United States
Fondation Ophtalmologique Adolphe de Rothschild
Ecouter Voir; Hoya Lens France

Recruiting

Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops (ATROSMART)

Myopia

France
Lawson Health Research Institute
Bristol-Myers Squibb

Completed

Aripiprazole and Resistant Postpartum Depression

Postpartum Depression

Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Alzheimer Disease

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Effect on Cognitive Function of a Treatment With Aripiprazole

Schizophrenia
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Refractory Anxiety

Generalized Anxiety Disorder | Panic Disorder

United States
Creighton University
Bristol-Myers Squibb

Completed

Abilify Therapy for Reducing Comorbid Substance Abuse

Schizophrenia | Schizoaffective Disorder | Anxiety Disorders | Bipolar Disorder | Major Depressive Disorder | Substance Abuse

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Autistic Disorder

Japan
Yu-Li Hospital

Unknown

The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Schizophrenia

United States
Alkermes, Inc.

Completed

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Tic Disorder | Tourette's Disorder

United States, Germany, Spain, Mexico, Romania, Canada, Hungary, Italy, Sweden
Federal University of São Paulo

Completed

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (AripipPTSD)

Posttraumatic Stress Disorder
University of Medicine and Dentistry of New Jersey

Completed

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children (Abilify)

Autism

United States
Kettering Health Network

Terminated

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia (BEST)

Schizophrenia

United States
Medical University of South Carolina

Completed

Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) (BAART)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Romania, Russian Federation, Ukraine
US Department of Veterans Affairs

Withdrawn

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Methamphetamine Dependence
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Si Tianmei

Unknown

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Sexual Dysfunction | Hyperprolactinemia

China
Réseau de Santé Vitalité Health Network
Janssen Inc.

Unknown

Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

Schizophrenia Spectrum and Other Psychotic Disorders

Canada
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE- EU)

Schizophrenia

Belgium, Bulgaria, Canada
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Reactivity and Consumption

Alcohol Dependence

United States
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness (SMART-A)

Bipolar Disorder

Korea, Republic of
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

Tourette Syndrome

China
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

Schizophrenia | Schizoaffective Disorder | First Episode Psychosis

United Kingdom
National Institute of Mental Health (NIMH)

Completed

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder (CAMP)

Schizophrenia | Schizoaffective Disorder

United States
University of Pittsburgh

Completed

Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY) (IRL GREY)

Depression

United States, Canada
New York State Psychiatric Institute

Withdrawn

A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults

Major Depressive Disorder | Dysthymic Disorder | Depressive Disorder Not Otherwise Specified (NOS)

United States

Search clinical trials for: Variant of Defocus Incorporated Spectacle lens (DG2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations